- Investing Ideas
- U.S. Pharmaceuticals & Biotech Breakout Stocks
U.S. Pharmaceuticals & Biotech Breakout Stocks
Results
11
Stocks where the price continues to rise after more than a year of consistent gains.
11 companies
Eton Pharmaceuticals
Market Cap: US$1.7b
A pharmaceutical company, focuses on developing and commercializing treatments for rare diseases.
ETON
US$61.73
7D
41.4%
1Y
277.1%
Omeros
Market Cap: US$1.2b
A clinical-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting immunologic diseases.
OMER
US$17.36
7D
27.5%
1Y
310.9%
Climb Bio
Market Cap: US$937.9m
A clinical-stage biotechnology company, focuses on developing therapies to address unmet needs for patients living with immune-mediated diseases.
CLYM
US$17.44
7D
28.8%
1Y
726.5%
4D Molecular Therapeutics
Market Cap: US$673.4m
A late-stage biotechnology company, engages in the development of adeno-associated virus vectors from its proprietary synthetic vector discovery platform, Therapeutic Vector Evolution in the Netherlands and the United States.
FDMT
US$14.55
7D
30.6%
1Y
100.1%
Apollomics
Market Cap: US$51.4m
A clinical-stage biopharmaceutical company, engages in the discovery and development of oncology therapies to harness the immune system and target specific molecular pathways to inhibit cancer.
APLM
US$23.55
7D
31.9%
1Y
313.2%
OSR Health
Market Cap: US$11.1m
A healthcare holding company, develops a portfolio of therapies and healthcare solutions in the United States, Europe, and Korea.
OSRH
US$0.59
7D
43.7%
1Y
5.0%
Brainstorm Cell Therapeutics
Market Cap: US$10.9m
A biotechnology company, engages in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases.
BCLI
US$1.09
7D
37.4%
1Y
75.1%
Hepion Pharmaceuticals
Market Cap: US$6.7m
A biopharmaceutical company, focuses on the development of treatment for hepatocellular carcinoma (HCC), metabolic liver diseases, and chronic liver diseases in the United States.
HEPA
US$0.075
7D
25.0%
1Y
15.7%
Enzolytics
Market Cap: US$2.9m
A drug development company, focuses to the commercialization of its proprietary proteins for the treatment of debilitating infectious diseases.
ENZC
US$0.0006
7D
20.0%
1Y
0%
International Stem Cell
Market Cap: US$2.8m
A clinical stage biotechnology company, focuses on the development of therapeutic and biomedical products in the United States, Asia, Europe, and internationally.
ISCO
US$0.40
7D
32.7%
1Y
121.0%
Hero Technologies
Market Cap: US$56.4k
Operates as an early-stage cannabis company.
HENC
US$0.0001
7D
9,900.0%
1Y
0%